Abstract:Background: WHO issued the first edition catalogue of Mycobacterium tuberculosis complex (MTBC) mutations associated with drug resistance in 2021. However, country-specific issues might lead to arising complex and additional drug-resistant mutations. We aimed to fully reflect the characteristics of drug resistance mutations in China. Methods: We analysed MTBC isolates from the nationwide drug-resistant tuberculosis surveillance with 70 counties in 31 provinces, municipalities, and autonomous regions in China. Three types of MYCOTB plates were used to perform drug susceptibility testing for 12 antibiotics (rifampicin, isoniazid, ethambutol, levofloxacin, moxifloxacin, amikacin, kanamycin, ethionamide, clofazimine, linezolid, delamanid, and bedaquiline). Mutations were divided into five groups according to their odds ratios, positive predictive values, false discovery rate-corrected p values, and 95% CIs: (1) associated with resistance; (2) associated with resistance-interim; (3) uncertain significance; (4) not associated with resistance-interim; and (5) not associated with resistance. The Wilcoxon rank-sum and Kruskal-Wallis tests were used to quantify the association between mutations and minimum inhibitory concentrations (MICs). Our dataset was compared with the first edition of the WHO catalogue. Findings: We analysed 10 146 MTBC isolates, of which 9071 (89·4%) isolates were included in the final analysis. 744 (8·2%) isolates were resistant to rifampicin and 1339 (14·8%) to isoniazid. 208 (1·9%) of 11 065 mutations were classified as associated with resistance or associated with resistance-interim. 33 (97·1%) of 34 mutations in group 1 and 92 (52·9%) of 174 in group 2 also appeared in groups 1 or 2 of the WHO catalogue. Of 81 indel mutations in group 2, 15 (18·5%) were in the WHO catalogue. The newly discovered mutation gyrA_Ala288Asp was associated with levofloxacin resistance. MIC values for rifampicin, isoniazid, moxifloxacin, and levofloxacin corresponding to resistance mutations in group 1 were significantly different (p<0·0001), and 12 high-level resistance mutations were detected. 61 mutations in group 3 occurred as solo in at least five phenotypically susceptible isolates, but with MIC values moderately higher than other susceptible isolates. Among 945 phenotypically resistant but genotypically susceptible isolates, 433 (45·8%) were mutated for at least one efflux pump gene. Interpretation: Our analysis reflects the complexity of drug resistance mutations in China and suggests that indel mutations, efflux pump genes, protein structure, and MICs should be fully considered in the WHO catalogue, especially in countries with a high tuberculosis burden. Funding: National Key Research and Development Program of China and the Science and Technology Major Project of Tibetan Autonomous Region of China.

A Deletion in the RD105 Region Confers Resistance to Multiple Drugs in Mycobacterium Tuberculosis

Longitudinal Molecular Epidemiological Study of Multidrug Resistant Tb and Transition to Extensively Drug Resistance in Eastern Rual China

Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from South-central in China

Whole Genome Analysis of an Mdr Beijing/W Strain of Mycobacterium Tuberculosis with Large Genomic Deletions Associated with Resistance to Isoniazid

A Genome-Wide Analysis of Multidrug-Resistant and Extensively Drug-Resistant Strains of Mycobacterium Tuberculosis Beijing Genotype.

Identification of drug resistance-related virulence gene mutations in 667 clinical Mycobacterium tuberculosis isolates

Genomic Sequence Based Scanning for Drug Resistance-Associated Mutations and Evolutionary Analysis of Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium Tuberculosis

Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment

Molecular Characterization of Multidrug- and Extensively Drug-Resistant Mycobacterium Tuberculosis Strains in Jiangxi, China

[Analysis on Drug Resistance-Associated Mutations of Multi-Drug Resistant Mycobacterium Tuberculosis Based on Whole-Genome Sequencing in China].

One Member of Beijing Genotype Associated with Multi-Drug Resistance and Increased Transmissibility in Rural Chinese Populations

Identification of region of difference and H37Rv-related deletion in Mycobacterium tuberculosis complex by structural variant detection and genome assembly

Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition

Genotypic Analysis of Multidrug-Resistant Mycobacterium Tuberculosis Isolates Recovered from Central China.

Genetic Characterisation of Drug-Resistant Mycobacterium Tuberculosis in Rural China: a Population-Based Study.

Identification of Novel Mutations Associated with Cycloserine Resistance Inmycobacterium Tuberculosis

Mutations in the Rpob Gene of Multidrug-Resistant Mycobacterium Tuberculosis Isolates from China.

Emergence and evolution of drug-resistant Mycobacterium tuberculosis in eastern China: A six-year prospective study

The catalogue of Mycobacterium tuberculosis mutations associated with drug resistance to 12 drugs in China from a nationwide survey: a genomic analysis

A Profile of Drug-Resistant Mutations in Mycobacterium tuberculosis Isolates from Guangdong Province, China

Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: A molecular epidemiological study